Comparison of plasma protein binding of basic drugs in black and white individuals

American Journal of Therapeutics

Volumn 3, Issue 9, 1996, Pages 611-615

  Edeki, Timi ^a   Dillon Moore, Betty ^b   He, Nu ^b  

^a MEHARRY MEDICAL COLLEGE   (United States)

^b NONE

Author keywords

alpha 1 acid glycoprotein; black Americans; ethnicity; protein binding; white Americans

Indexed keywords

ALBUMIN; AURAMINE; BROMOCRESOL GREEN; DIAZEPAM; DISOPYRAMIDE; LIDOCAINE; OROSOMUCOID; PROPRANOLOL; VERAPAMIL;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DISPOSITION; DRUG PROTEIN BINDING; ETHNIC DIFFERENCE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PLASMA PROTEIN BINDING; PRIORITY JOURNAL;

EID: 0029998576     PISSN: 10752765     EISSN: None     Source Type: Journal    
DOI: 10.1097/00045391-199609000-00002     Document Type: Article

References (16)

1. Wood AJJ, Zhou HH: Ethnic differences in drug disposition and responsiveness. Clin Pharmacokinet 1991;20:350-373.
2. Kremer JMH, Wilting J, Janssen LHM: Drug binding to human alpha-1-acid glycoprotein in health and disease. Pharmacol Rev 1988;40:1-47.
3. Zhou HH, Adedoyin A, Wilkinson GR: Differences in plasma binding of drugs between Caucasians and Chinese subjects. Clin Pharmacol Ther 1990;48:10-17.
4. Rodkey FL: Direct spectrophotometric determination of albumin in human serum. Clin Chem 1965;11:478-487.
5. Sugiyama Y, Yasuyuki S, Yasufumi S, Kawasaki S, Beppu T, Iga T, Hanano M: Auramine O as a fluorescent probe for the binding of basic drugs to human α1-acid glycoprotein (α1-AG). Biochem Pharmacol 1985;34:821-829.
6. Kishino S, Nomura A, Suo Z, Sugawara M, Iseki K, Kakinoki S, Kitabatake A, Miyazaki K: Alpha-1-acid glycoprotein concentration and the protein binding of disopyramide in healthy subjects. J Clin Pharmacol 1995;35:510-514.
7. Alexanderson B, Borga O: Interindividual differences in plasma protein binding of nortriptyline in man - A twin study. Eur J Clin Pharmacol 1972;4:196-200.
8. Alvan G, Bergstrom K, Borga O, Iselius L, Pedersen N: Family study of genetic and environmental factors determining the protein binding of propranolol. Eur J Clin Pharmacol 1983;25:437-441.
9. Benedek IH, Blouin RA, McNamara PJ: Influence of smoking on serum protein composition and the protein binding of drugs. J Pharm Pharmacol 1984;36:214-216.
10. Edwards DJ, Pharm D, Lalka D, Cerra F, Slaughter RL: Alpha-1-acid glycoprotein concentration and protein binding in trauma. Clin Pharmacol Ther 1982;31:62-67.
11. Morita K, Yamaji A: Changes in the concentration of serum alpha 1-acid glycoprotein in epileptic patients. Eur J Clin Pharmacol 1994;46:137-142.
12. Jackson PR, Tucker GT, Woods HF: Altered plasma drug binding in cancer: Role of α1-acid glycoprotein and albumin. Clin Pharmacol Ther 1982;32:295-302.
13. Routledge PA, Shand DG, Barchowsky A, Wagner G, Stargel WW: Relationship between α1-acid glycoprotein and lidocaine disposition in myocardial infarction. Clin Pharmacol Ther 1981;30:154-157.
14. Kalow W: Ethnic differences in drug metabolism. Clin Pharmacokin 1982;7:373-400.
15. Spector R, Choudhury AK, Chiang C, Goldberg MJ, Ghoneim MM: Diphenhydramine in Orientals and caucasians. Clin Pharmacol Ther 1980;28:229-234.
16. Johnson JA, Burlew BS: Racial differences in propranolol pharmacokinetics. Clin Pharmacol Ther 1992;51:495-500.